financetom
Business
financetom
/
Business
/
Village Farms Unit Gets License for Cannabis Research in Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Village Farms Unit Gets License for Cannabis Research in Canada
Aug 1, 2024 11:14 AM

01:48 PM EDT, 08/01/2024 (MT Newswires) -- Village Farms International's ( VFF ) Rose LifeScience said Thursday it received a cannabis research license in Canada.

The license would let Rose LifeScience conduct non-therapeutic research on cannabis to develop products tailored to consumer preference.

Price: 1.12, Change: -0.02, Percent Change: -1.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment
Oct 20, 2025
Overview * STAAR Surgical ( STAA ) Q3 preliminary net sales rise 6.9% yr/yr, beating analyst expectations * Sales growth driven by recognition of deferred China shipment * Lower new orders from China due to leaner inventory management Outlook * STAAR Surgical ( STAA ) did not provide specific future guidance in its press release Result Drivers * DEFERRED CHINA...
Alto Neuroscience Signs $50 Million PIPE Financing Deal
Alto Neuroscience Signs $50 Million PIPE Financing Deal
Oct 20, 2025
07:42 AM EDT, 10/20/2025 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Monday that it signed a securities purchase agreement with institutional and accredited investors for a $50 million private investment in public equity, or PIPE, financing. The company is selling about 3.8 million common shares at $5.914 each and pre-funded warrants to purchase up to about 4.6 million...
Glaukos Says Drug Treating Keratoconus Receives FDA Approval
Glaukos Says Drug Treating Keratoconus Receives FDA Approval
Oct 20, 2025
07:40 AM EDT, 10/20/2025 (MT Newswires) -- Glaukos ( GKOS ) said Monday its new drug application for Epioxa, a topical drug therapy for the eye disorder keratoconus, has been approved by the US Food and Drug Administration. The approval of the drug is based on results from two phase 3 pivotal trials of over 400 patients that achieved their...
Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices
Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices
Oct 20, 2025
07:40 AM EDT, 10/20/2025 (MT Newswires) -- Apple ( AAPL ) is facing a complaint filed with China's market regulator alleging abuse of its market position by restricting app distribution and payments to its own iOS platform on iPhones and iPads, Reuters reported Monday. The report cited a lawyer as saying that a filing to China's State Administration for Market...
Copyright 2023-2026 - www.financetom.com All Rights Reserved